Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DASATINIB vs DEFERASIROX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DASATINIB vs DEFERASIROX: Safety Overview

Metric DASATINIB DEFERASIROX
Total FAERS Reports 30,019 11,322
Deaths Reported 2,681 2,661
Death Rate 8.9% 23.5%
Hospitalizations 6,437 4,008
Average Patient Age 56.4 yrs 49.8 yrs
% Female Patients 51.9% 50.1%
FDA Approval Date Apr 22, 2025 Apr 11, 2025
Manufacturer Zydus Pharmaceuticals USA Inc. AvKARE
Route ORAL ORAL
Marketing Status Prescription Prescription